Latest Press Releases

Market Data Forecast Says Infectious Disease Therapeutics Market Expected Huge Growth in Future

LogoAccording to a new market research report " Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antifungal, Antiviral, Antiparasitic, Antibacterial, others) by infection type – (Viral, fungal, Parasitic, Bacterial, others), by distribution channels (Hospitals, Clinics and others) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", published by MarketDataForecast, The Global Infectious Disease Therapeutics Market was worth USD 475 Million in 2016 and assessed to develop at a CAGR of 8.5%, to reach USD 714.24 Million by 2021. The Infectious Disease Therapeutics Market is principally driven by factors such as increasing geriatric population across the globe coupled with the rise in the healthcare. Another prominent factor responsible for the market growth is increasing the use of Anti-viral owing to rise in the occurrence of infectious diseases among individuals. However, increasing the number of patent expirations of various infectious disease drugs and lack of awareness about treatments are hindering the market growth.

BriaCell Opens Fourth Clinical Site in Advanced Breast Cancer

LogoBriaCell Therapeutics Corp.("BriaCell"), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the opening of a new clinical site, Jefferson Breast Care Center in Philadelphia, PA, and the appointment of Dr. Saveri Bhattacharya, a board certified medical oncologist, as the clinical site's principal investigator. Dr. Bhattacharya will work closely with Cancer Insight, LLC., BriaCell's contract research organization, to manage the clinical and regulatory aspects of the clinical trial on behalf of BriaCell.